EMERGENCE OF EXTENSIVE DRUG RESISTANCE TYPHOID IN HOSPITALIZED COVID-19 PATIENTS IN SOUTH PUNJAB, PAKISTAN

Main Article Content

Safdar Ali
Muhammad Moazam Jalees
Waqas Ashraf
Maimona Sadia
Rafia Anwar
Saleha Zafar
Muhammad Tariq Mahmood
Muhammad Rizwan
Abdul Mannan

Keywords

XDR, COVID-19, typhoid, Salmonella typhi, S. Typhi, MDR

Abstract

Introduction: In Pakistan, one of the main causes of mortality and morbidity is typhoid fever. Notably, extended drug-resistant (XDR) typhoid has been misdiagnosed widely due to many physicians continued use of Widal and Typhi-dot as serological tests for diagnosis during the COVID-19 pandemic. There were increased cases of extensively drug-resistant typhoid due to the use of extended drugs during the COVID-19 pandemic without confirming the antimicrobial susceptibility of Salmonella typhi.


Methodology: In this study, 118 patient blood samples after the COVID-19 pandemic was analyzed by automated blood culture through BacT/ALERT 3D, and antimicrobials susceptibility was performed. And compared with the antimicrobial susceptibility before the COVID-19 pandemic samples of the same patients.


Results: Out of 118 blood cultures of Post-COVID-19 isolates, 34 cultures were positive for Salmonella typhi. On antibiotic susceptibility test profiling of these 34 isolates, 44.12% were extensive drug-resistant (XDR), 38.24% were multidrug-resistant (MDR), 8.82% were non-MDR, non-XDR and 8.82% were resistant to all antibiotics. While in Pre-COVID-19 isolates 21.74% were XDR, 60.87% were MDR, 17.39% were non-MDR, non-XDR and 0.0% were resistant to all antibiotics. There were an increased XDR typhoid ratio as compared to MDR typhoid in Post-COVID-19 isolates.


Conclusions: There is an increased emergence of XDR typhoid cases in Post-COVID-19 isolates of Salmonella typhi as compared to the Pre-COVID-19 Salmonella typhi isolates. Moreover, implementing antimicrobial susceptibility profiling and proper diagnosis before using any antibiotic against Salmonella typhi prevent the XDR typhoid outbreak in the near future.

Abstract 527 | PDF Downloads 48

References

1. Aiemjoy K, Seidman JC, Saha S, Munira SJ, Sajib MS, Al Sium SM, Sarkar A, Alam N, Zahan FN, Kabir MS, Tamrakar D (2022) Estimating typhoid incidence from community-based serosurveys: a multicohort study. The Lancet Microbe. Aug 1;3(8):e578-87.
2. Irfan S, Zeeshan M, Rattani S, Farooqi J, Shakoor S, Hasan R, Zafar A (2021) Extraintestinal seeding of salmonella enterica serotype typhi, Pakistan. Emerging Infectious Diseases. Mar;27(3):936.
3. Andino A, Hanning I (2015) Salmonella enterica: survival, colonization, and virulence differences among serovars. The Scientific World Journal.Oct;2015.
4. Khan M, Shamim S (2022) Understanding the mechanism of antimicrobial resistance and pathogenesis of Salmonella enterica Serovar Typhi. Microorganisms. Oct 11;10(10):2006.
5. Lamy E, Viegas C, Rocha A, Lucas MR, Tavares S, e Silva FC, Guedes D, Laureati M, Zian Z, Machado AS, Ellssel P (2022) Changes in food behavior during the first lockdown of COVID-19 pandemic: A multi-country study about changes in eating habits, motivations, and food-related behaviors. Food quality and preference. Jul 1;99:104559.
6. Jeon HJ, Marks F, Sugimoto J, Im J, Kang SS, Haselbeck A, Rakotozandrindrainy R (2021) Surge of typhoid intestinal perforations as possible result of COVID-19–associated delays in seeking care, Madagascar. Emerging Infectious Diseases. Dec;27(12):3163.
7. Yazdanpanah F, Hamblin MR, Rezaei NJLs (2020) The immune system and COVID-19: Friend or foe? Sep 1;256:117900.
8. Haqqi A, Khurram M, Din MS, Aftab MN, Ali M, Ahmed H, Afzal MS (2022) COVID‐19 and Salmonella Typhi co‐epidemics in Pakistan: a real problem. Journal of medical virology. Jan;93(1):184.
9. Acharya PC, Kurosu M Introduction to chemotherapy: general and clinical considerations. InMedicinal Chemistry of Chemotherapeutic Agents. Academic Press.
10. Majumder MA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, Gittens-St Hilaire M (2020) Antimicrobial stewardship: Fighting antimicrobial resistance and protecting global public health. Infection and drug resistance. Dec 29:4713-38.
11. Ackers ML, Puhr ND, Tauxe RV, Mintz ED (2000) Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. Jama. May 24;283(20):2668-73.
12. Saeed N, Usman M, Khan EA (2019) An overview of extensively drug-resistant Salmonella Typhi from a tertiary care hospital in Pakistan. Cureus. Sep 16;11(9).
13. Umair M, Siddiqui SA (2020) Antibiotic susceptibility patterns of Salmonella typhi and Salmonella paratyphi in a tertiary care hospital in Islamabad. Cureus. Sep 3;12(9).
14. Gupta V, Singla N, Bansal N, Kaistha N, Chander J (2013) Trends in the antibiotic resistance patterns of enteric fever isolates–A three year report from a tertiary care centre. The Malaysian journal of medical sciences: MJMS. Jul;20(4):71.
15. Zakir M, Khan M, Umar MI, Murtaza G, Ashraf M, Shamim S (2021) Emerging trends of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Salmonella Typhi in a tertiary care Hospital of Lahore, Pakistan. Microorganisms. Nov 30;9(12):2484.
16. Karkey A, Thwaites GE, Baker S (2018) The evolution of antimicrobial resistance in Salmonella Typhi. Current Opinion in Gastroenterology. Jan 1;34(1):25-30.
17. Rasheed F, Saeed M, Alikhan NF, Baker D, Khurshid M, Ainsworth EV, Turner AK, Imran AA, Rasool MH, Saqalein M, Nisar MA (2020) Emergence of resistance to fluoroquinolones and third-generation cephalosporins in Salmonella Typhi in Lahore, Pakistan. Microorganisms. Sep 1;8(9):1336.
18. Klemm EJ, Shakoor S, Page AJ, Qamar FN, Judge K, Saeed DK, Wong VK, Dallman TJ, Nair S, Baker S, Shaheen G (2018) Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins. MBio. Mar 7;9(1):10-128.
19. Qamar FN, Yousafzai MT, Khalid M, Kazi AM, Lohana H, Karim S, Khan A, Hotwani A, Qureshi S, Kabir F, Aziz F (2018) Outbreak investigation of ceftriaxone-resistant Salmonella enterica serotype Typhi and its risk factors among the general population in Hyderabad, Pakistan: a matched case-control study. The Lancet Infectious Diseases. Dec 1;18(12):1368-76.
20. Seethalakshmi PS, Charity OJ, Giakoumis T, Kiran GS, Sriskandan S, Voulvoulis N, Selvin J (2022) Delineating the impact of COVID-19 on antimicrobial resistance: An Indian perspective. Science of The Total Environment. Apr 20;818:151702.
21. Saeed U, Uppal SR, Piracha ZZ, Uppal R (2021) Azithromycin treatment for SARS-CoV-2-related COVID-19 pandemic could worsen extensively drug resistant (XDR) typhoid: a risk of losing the last bullet against Salmonella enterica serovar typhi. Jundishapur Journal of Microbiology. Jan 31;14(1).
22 Kim C, Latif I, Neupane DP, Lee GY, Kwon RS, Batool A, Ahmed Q, Qamar MU, Song J (2021) The molecular basis of extensively drug-resistant Salmonella Typhi isolates from pediatric septicemia patients. PLoS One. Sep 28;16(9):e0257744.
23. Saeed M, Rasool MH, Rasheed F, Saqalein M, Nisar MA, Imran AA, Tariq S, Amir A, Ikram A, Khurshid M (2020) Extended-spectrum beta-lactamases producing extensively drug-resistant Salmonella Typhi in Punjab, Pakistan. The Journal of Infection in Developing Countries. Feb 29;14(02):169-76.
24. Fida S, Mansoor H, Saif S, Iqbal J, Khan AQ (2021) Clinical Perspectives of Multiple and Extensively Drug-Resistant Typhoid; result from a tertiary care hospital from Pakistan. The Journal of Infection in Developing Countries. Apr 30;15(04):530-7
25. Freeman JV, Campbell MJ (2007) The analysis of categorical data: Fisher’s exact test. Scope. Jun 7;16(2):11-2.
26. Pustake M, Giri P, Tambolkar S, Nayak S (2022) Extensively drug-resistant typhoid fever: A call to action. Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive & Social Medicine. Jan;47(1):153.
27. Ahmad S, Tsagkaris C, Aborode AT, Haque MT, Khan SI, Khawaja UA, dos Santos Costa AC, Essar MY, Lucero-Prisno III DE (2021) A skeleton in the closet: the implications of COVID-19 on XDR strain of typhoid in Pakistan. Public health in practice. Nov 1;2:100084.
28. Haqqi A, Awan UA, Ali M, Saqib MA, Ahmed H, Afzal MS (2021) COVID‐19 and dengue virus coepidemics in Pakistan: A dangerous combination for an overburdened healthcare system. Journal of medical virology. Jan;93(1):80.
29. Ahmad KA, Khan LH, Roshan B, Bhutta ZA (2011) Factors associated with typhoid relapse in the era of multiple drug resistant strains. The Journal of Infection in Developing Countries. Jul 5;5(10):727-31.
30. Aziz T, Haque SS (2012) Role of Widal test in the diagnosis of typhoid fever in context to other test. American Journal of Biochemistry 2(1):16-8.
31. Butt MH, Saleem A, Javed SO, Ullah I, Rehman MU, Islam N, Tahir MA, Malik T, Hafeez S, Misbah S (2022) Rising XDR-typhoid fever cases in Pakistan: are we heading back to the pre-antibiotic era?. Frontiers in public health. Jan 17;9:794868.
32. Shah SA, Nadeem M, Syed SA, Abidi ST, Khan N, Bano N (2020) Antimicrobial sensitivity pattern of Salmonella Typhi: emergence of resistant strains. Cureus. Nov 29;12(11).
33. Chatham-Stephens K, Medalla F, Hughes M, Appiah GD, Aubert RD, Caidi H, Angelo KM, Walker AT, Hatley N, Masani S, Nash J (2019) Emergence of extensively drug-resistant Salmonella Typhi infections among travelers to or from Pakistan—United States, 2016–2018. Morbidity and Mortality Weekly Report. Jan 1;68(1):11.
34. Saderi H, Owlia P (2015) Detection of multidrug resistant (MDR) and extremely drug resistant (XDR) P. aeruginosa isolated from patients in Tehran, Iran. Iranian journal of pathology 10(4):265.
35. Britto CD, Wong VK, Dougan G, Pollard AJ (2018) A systematic review of antimicrobial resistance in Salmonella enterica serovar Typhi, the etiological agent of typhoid. PLoS neglected tropical diseases. Oct 11;12(10):e0006779.

Most read articles by the same author(s)

1 2 > >>